Foresite Capital Management V, LLC's Net Worth
$0
Estimate Recalculated Nov 7, 2024 11:54AM EST
Who is Foresite Capital Management V, LLC?
Foresite Capital Management V, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PARDES BIOSCIENCES, INC., Aclaris Therapeutics, Inc., Kinnate Biopharma Inc., Theseus Pharmaceuticals, Inc., FS Development Corp., and ALUMIS INC..
SEC CIK
Foresite Capital Management V, LLC's CIK is 0001792206
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.18
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.58% | -1.95M |
—
|
—
| 8.28K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FS Development Corp. II No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.99% | -16.81M |
—
|
—
| 1K |
Aug 31
| |||
Form 4
| +6.04% | 773.95K |
$1.50 | $1,160,928.00 | 13.58M |
Apr 5
| |||
Form 4
| +5.24% | 637.42K |
$0.85 | $541,807.00 | 12.81M |
Dec 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4/A
|
∞
| 4.94M |
—
|
—
| 4.94M |
Dec 23
| |||
Form 4
|
∞
| 13.63M |
$10.00 | $10,000,000.00 | 13.63M |
Dec 23
| |||
Form 4
|
∞
| 325K |
$10.00 | $3,250,000.00 | 325K |
Dec 22
| |||
Form 4
|
∞
| 602.5K |
$10.00 | $6,025,000.00 | 602.5K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.60% | 700K |
$2.97 | $2,079,000.00 | 5.49M |
Jul 17
| |||
Form 4
| +11.64% | 500K |
$5.00 | $2,500,000.00 | 4.79M |
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $50.35
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.43M |
$10.00 | $15,000,000.00 | 4.43M |
Feb 5
| |||
Form 4
|
∞
| 441.5K |
$10.00 | $4,415,000.00 | 441.5K |
Aug 14
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kinnate Biopharma Inc. (KNTE) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.72M |
—
|
—
|
0
|
Apr 3
| |||
Form 4
| +78.53% | 1.78M |
$2.80 | $4,984,000.00 | 4.05M |
May 8
| |||
Form 4
| +125.71% | 1.1M |
—
|
—
| 1.98M |
Feb 17
| |||
Form 4
| +983.83% | 9.84M |
—
|
—
| 10.84M |
Dec 7
| |||
Form 4
|
∞
| 1M |
$20.00 | $20,000,000.00 | 1M |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||